Insider Selling: OrthoPediatrics (NASDAQ:KIDS) Insider Sells 8,596 Shares of Stock

OrthoPediatrics Corp. (NASDAQ:KIDS) insider Joseph Hauser sold 8,596 shares of the stock in a transaction on Monday, March 16th. The stock was sold at an average price of $17.25, for a total transaction of $148,281.00. Following the completion of the sale, the insider directly owned 194,767 shares of the company’s stock, valued at $3,359,730.75. The trade was a 4.23% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.

OrthoPediatrics Stock Up 0.6%

NASDAQ KIDS traded up $0.10 during trading hours on Tuesday, hitting $17.21. The company had a trading volume of 197,133 shares, compared to its average volume of 152,452. The firm’s 50 day moving average is $17.74 and its 200 day moving average is $17.97. The company has a debt-to-equity ratio of 0.28, a current ratio of 5.55 and a quick ratio of 2.65. OrthoPediatrics Corp. has a fifty-two week low of $15.28 and a fifty-two week high of $26.40. The company has a market capitalization of $435.07 million, a price-to-earnings ratio of -10.18 and a beta of 1.07.

OrthoPediatrics (NASDAQ:KIDS) last posted its earnings results on Thursday, February 26th. The company reported ($0.26) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.37) by $0.11. The business had revenue of $61.61 million during the quarter, compared to analyst estimates of $61.27 million. OrthoPediatrics had a negative return on equity of 6.70% and a negative net margin of 16.77%. Sell-side analysts anticipate that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have recently commented on the company. Wall Street Zen raised OrthoPediatrics from a “sell” rating to a “hold” rating in a report on Saturday, March 7th. Needham & Company LLC lifted their price target on shares of OrthoPediatrics from $26.00 to $30.00 and gave the stock a “buy” rating in a research report on Friday, February 27th. Canaccord Genuity Group started coverage on shares of OrthoPediatrics in a report on Wednesday, December 10th. They issued a “buy” rating and a $24.00 target price for the company. Weiss Ratings reiterated a “sell (e+)” rating on shares of OrthoPediatrics in a report on Thursday, January 22nd. Finally, BTIG Research boosted their target price on OrthoPediatrics from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Friday, February 27th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $24.67.

Hedge Funds Weigh In On OrthoPediatrics

Several institutional investors have recently added to or reduced their stakes in KIDS. Millennium Management LLC raised its position in OrthoPediatrics by 48.0% in the 4th quarter. Millennium Management LLC now owns 1,396,495 shares of the company’s stock worth $24,802,000 after purchasing an additional 452,840 shares during the last quarter. Vanguard Group Inc. increased its position in shares of OrthoPediatrics by 1.1% during the third quarter. Vanguard Group Inc. now owns 961,330 shares of the company’s stock worth $17,813,000 after acquiring an additional 10,927 shares in the last quarter. Marshall Wace LLP grew its holdings in shares of OrthoPediatrics by 6.0% during the third quarter. Marshall Wace LLP now owns 444,320 shares of the company’s stock worth $8,233,000 after buying an additional 25,191 shares in the last quarter. Prosight Management LP increased its stake in OrthoPediatrics by 319.2% in the 3rd quarter. Prosight Management LP now owns 308,707 shares of the company’s stock valued at $5,720,000 after buying an additional 235,060 shares during the last quarter. Finally, Goldman Sachs Group Inc. increased its position in shares of OrthoPediatrics by 112.3% in the first quarter. Goldman Sachs Group Inc. now owns 200,439 shares of the company’s stock valued at $4,937,000 after acquiring an additional 106,041 shares during the last quarter. 69.05% of the stock is owned by institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.